{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:05:47Z","timestamp":1777575947515,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009087","name":"Universidad Industrial de Santander","doi-asserted-by":"publisher","award":["5839"],"award-info":[{"award-number":["5839"]}],"id":[{"id":"10.13039\/501100009087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009087","name":"Universidad Industrial de Santander","doi-asserted-by":"publisher","award":["771"],"award-info":[{"award-number":["771"]}],"id":[{"id":"10.13039\/501100009087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009087","name":"Universidad Industrial de Santander","doi-asserted-by":"publisher","award":["687 -2014"],"award-info":[{"award-number":["687 -2014"]}],"id":[{"id":"10.13039\/501100009087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.exppara.2021.108206","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T02:52:14Z","timestamp":1640746334000},"page":"108206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vitro selection of ketoconazole-pentamidine-resistant Leishmania (Viannia) braziliensis strains"],"prefix":"10.1016","volume":"233","author":[{"given":"Mary El\u00edzabeth","family":"Salazar-Villamizar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-2364","authenticated-orcid":false,"given":"Patricia","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2021.108206_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1039\/D0MD00101E","article-title":"Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana","volume":"11","author":"Ahmed","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.exppara.2021.108206_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1590\/S0074-02762012000300018","article-title":"The stepwise selection for ketoconazole resistance induces upregulation of C14-demethylase (CYP51) in Leishmania amazonensis","volume":"107","author":"Andrade-Neto","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2021.108206_bib3","first-page":"943236","article-title":"In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis","author":"Baptista","year":"2015","journal-title":"Dis. Markers"},{"key":"10.1016\/j.exppara.2021.108206_bib4","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.46.12.3731-3738.2002","article-title":"Resistance to pentamidine in Leishmania mexicana Involves exclusion of the drug from the mitochondrion","volume":"46","author":"Basselin","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2021.108206_bib6","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.42.12.3245","article-title":"Induction of resistance to azole drugs in Trypanosoma cruzi","volume":"42","author":"Buckner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2021.108206_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01399-18","article-title":"Leishmania Genome dynamics during environmental adaptation reveal strain-specific differences in gene copy number variation, karyotype instability, and telomeric amplification","volume":"9","author":"Bussotti","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.exppara.2021.108206_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-6851(03)00162-2","article-title":"Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major","volume":"130","author":"Coelho","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2021.108206_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exppara.2008.03.018","article-title":"Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine","volume":"120","author":"Coelho","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108206_bib11","series-title":"Formulaci\u00f3n farmac\u00e9utica t\u00f3pica de isetionato de pentamidina y un principio activo seleccionado entre ketoconazol y miltefosina","author":"Escobar Rivero","year":"2021"},{"key":"10.1016\/j.exppara.2021.108206_bib12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4269\/ajtmh.16-0811","article-title":"Susceptibility to miltefosine in Brazilian clinical isolates of Leishmania (Viannia) braziliensis","volume":"96","author":"Espada","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2021.108206_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/mdr.2016.0095","article-title":"Mutations and\/or overexpressions of ERG4 and ERG11 genes in clinical azoles-resistant isolates of Candida albicans","volume":"23","author":"Feng","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.exppara.2021.108206_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"Fern\u00e1ndez","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003704","article-title":"Fitness of Leishmania donovani parasites resistant to drug combinations","volume":"9","author":"Garc\u00eda-Hern\u00e1ndez","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001974","article-title":"Leishmania donovani develops resistance to drug combinations","volume":"6","author":"Garc\u00eda-Hern\u00e1ndez","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib17","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/jac\/dkw096","article-title":"Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum","volume":"71","author":"Hendrickx","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib18","doi-asserted-by":"crossref","first-page":"e1664","DOI":"10.1371\/journal.pntd.0001664","article-title":"Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol","volume":"6","author":"Hendrickx","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005620","article-title":"Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum","volume":"11","author":"Hendrickx","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib20","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":"In Vivo Selection of paromomycin and miltefosine resistance in Leishmania donovani and L. infantum in a Syrian hamster model","volume":"59","author":"Hendrickx","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/expr.1996.0053","article-title":"Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms","volume":"83","author":"Hodgkinson","year":"1996","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2021.108206_bib22","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.12688\/f1000research.9218.1","article-title":"Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance","volume":"5","author":"Laffitte","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.exppara.2021.108206_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2021.108206_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-010-1852-8","article-title":"Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species","volume":"107","author":"Liarte","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2021.108206_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib27","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1007\/BF02561666","article-title":"Combination therapy as a tool to prevent emergence of bacterial resistance","volume":"27","author":"Mouton","year":"1999","journal-title":"Infection"},{"key":"10.1016\/j.exppara.2021.108206_bib28","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jac\/dkz049","article-title":"Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis","volume":"74","author":"Neira","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.01023-13","article-title":"Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania Subgenus Viannia species","volume":"58","author":"Obonaga","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2021.108206_bib32","series-title":"Pan American Health Organization: Leishmaniasis in the Americas: Treatment Recommendations","year":"2013"},{"key":"10.1016\/j.exppara.2021.108206_bib33","series-title":"Microbiology: Application Based Approach","author":"Pelczar","year":"2010"},{"key":"10.1016\/j.exppara.2021.108206_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004739","article-title":"Clinical and parasitological features of patients with American cutaneous leishmaniasis that did not respond to treatment with meglumine antimoniate","volume":"10","author":"Perez-Franco","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib35","first-page":"279","article-title":"Characterizing the effect of pentamidine isethionate on the immune system using mouse splenocytes as an experimental model","volume":"4","author":"Plaza","year":"2007","journal-title":"J. Immunot."},{"key":"10.1016\/j.exppara.2021.108206_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib38","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.exppara.2021.108206_bib39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1128\/AAC.01460-09","article-title":"Compensation of fitness costs and reversibility of antibiotic resistance mutations","volume":"54","author":"Schulz zur Wiesch","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.exppara.2021.108206_bib43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/AAC.41.9.1898","article-title":"In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced","volume":"41","author":"Sereno","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2021.108206_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/516267","article-title":"Topical paromomycin\/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study","volume":"26","author":"Soto","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2021.108206_bib45","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasite"},{"key":"10.1016\/j.exppara.2021.108206_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to extend the life of antibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.exppara.2021.108206_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/1040841X.2012.716818","article-title":"Drug-resistant microorganisms with a higher fitness \u2013 can medicines boost pathogens?","volume":"39","author":"Vanaerschot","year":"2013","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.exppara.2021.108206_bib48","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.exppara.2021.108206_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421001430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489421001430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:27:04Z","timestamp":1777404424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489421001430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":49,"alternative-id":["S0014489421001430"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108206","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro selection of ketoconazole-pentamidine-resistant Leishmania (Viannia) braziliensis strains","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2021.108206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108206"}}